David Wald
Clinical trials sponsored by David Wald, explained in plain language.
-
Speedy cell therapy trial aims to tame blood cancer
Disease control OngoingThis early-stage study tests a new, fast-made CAR-T cell therapy (UF-KURE19) in 21 adults with B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The main goal is to check the therapy's safety and find the right dose. Researchers also want to see if it …
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Boosting Cancer-Killing cells: a new combo therapy trial
Disease control TerminatedThis early-phase trial tests whether giving healthy donor NK cells along with two drugs (vactosertib and IL-2) is safe and helps the cells survive longer in people with advanced colorectal, stomach/esophageal, or blood cancers. About 12 participants will receive the combination t…
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated May 11, 2026 20:48 UTC